| For: | Singh AK, Durairajan SSK, Iyaswamy A, Williams LL. Elucidating the role of gut microbiota dysbiosis in hyperuricemia and gout: Insights and therapeutic strategies. World J Gastroenterol 2024; 30(40): 4404-4410 [PMID: 39494101 DOI: 10.3748/wjg.v30.i40.4404] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i40/4404.htm |
| Number | Citing Articles |
| 1 |
Yizhi Jing, Xiaoyue Bai, Haidong Qian, Yue Wang, Yan Hao, Zhengyuan Zhai, Zhu Zhang, Yanling Hao. Limosilactobacillus reuteri Urob-7 Alleviates Hyperuricemia by Modulating Uric Acid Metabolism Through Nucleoside Degradation and Xanthine Oxidase Inhibition. Foods 2025; 14(21) doi: 10.3390/foods14213706
|
| 2 |
Sara Abigail Paredes Pilco, Diego Raúl Bonifaz Díaz. La relación entre la disbiosis intestinal e insuficiencia renal crónica: implicaciones fisiopatológicas y terapéuticas. Esprint Investigación 2026; 5(1) doi: 10.61347/ei.v5i1.236
|
| 3 |
Ying Yang, Yu Wang, Jinjian Huang, Yi Xu, Xiaoyang Yin, Zhijian Lin, Bing Zhang. Influence of Gut Microbiota-Derived Butyrate on Intestinal Uric Acid Excretion and Hyperuricemia Regulation by Cichorium intybus L.. International Journal of Molecular Sciences 2025; 26(13) doi: 10.3390/ijms26136413
|
| 4 |
F.A. Yusupov, M.Sh. Abdykadyrov. Gut ecosystem: a new insight on hyperuricemia mechanisms. Russian Journal of Preventive Medicine 2026; 29(1) doi: 10.17116/profmed202629011123
|
| 5 |
Kai Li, Fanglin Jin, Songsong Tan, Xiang Zeng, Dongbo Yuan, Fuxing Shu, Jishuang Chen, Jian-Ming Ouyang, Liyan Zhang, Can Li, Jianguo Zhu. Cinchonain Ia inhibits uric acid reabsorption by binding to the TRP-459 residue of the GLUT9 protein. Phytomedicine 2026; 157 doi: 10.1016/j.phymed.2026.158292
|
| 6 |
Chuankai Shi, Lemeng Li, Wenping Ge, Yuan Gao, Yiyang Li, Wuhui Li, Jiangwei Liu. The role of the gut microbiota-uric acid metabolism axis in high-altitude hyperuricemia: dysregulation mechanisms, pathway associations and therapeutic perspectives. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1882007
|
| 7 |
Tingli Qu, Nan Zhang, Junjie Cai, Chen Li, Yue Zhang, Xinxue Xu, Shuai Zhang, Wangwei Lv, Taigang Liang. Integrated bioinformatics and multi-omics reveal Astragalus extract’s gut-kidney axis mechanism in hyperuricemic nephropathy via purine metabolism. Phytomedicine 2025; 146 doi: 10.1016/j.phymed.2025.157121
|
| 8 |
Youliang Zhang, Hengyu Zhang, Tianwen Miao, Xuetao Wang, Yanan Zuo, Renwei Zhang, Liangtong Zhang, Yuan Cheng, Dong Liu, Xin Chen, Longcan Li, Xingwen Xie, Ning Li. Advances in the study of gut microecology and mechanisms of hyperuricemia and gouty arthritis. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1738716
|
| 9 |
Meiling Wang, Ruifang Yang, Honglin An, Bingyan Chen, Qianglong Chen, Zejun Chen, Mengyuan Li, Fan Yang, Yan Xiao, Peng Chen, Jiemei Guo, Youxin Su, Bin Huang. Gut microbiota and uric acid excretion signaling in pathogenesis of hyperuricemia and acute gouty arthritis. iScience 2026; 29(9) doi: 10.1016/j.isci.2026.117072
|
| 10 |
Yanling Che, Lina Zhao, Haoxuan Xu, Yijiao Cai, Ziqi Wu, Lili Zhong. Serum uric acid to high‑density lipoprotein cholesterol ratio as a novel predictor of diabetic nephropathy: a cross‑sectional analysis of NHANES 2011–2018. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01893-8
|
| 11 |
Wei-Ting Tseng, Xiang-Ru Kong, Yu-Tsung Han, Wen-Yang Lin, Deyi Yin, Lei Du, Jingli Xie, Tien-Hung Chang. Lacticaseibacillus paracasei LT12—A Probiotic Strain That Reduces Hyperuricemia via Inhibiting XO Activity and Regulating Renal Uric Acid Transportation Protein. Fermentation 2025; 11(2) doi: 10.3390/fermentation11020096
|
| 12 |
Yukun Li, Rongshuang Han, Rong Wang, Xiaoyan Zhang, Mengchen Shan, Tianyu Fu, Yupeng Li, Xingsi Qi, Bin Cao, Yi Wang, Tao Mao, Zibin Tian. Alginate alleviates hyperuricemia by modulating the Pediococcus acidilactici LW1-1–butyrate–NLRP3 inflammasome axis. International Journal of Biological Macromolecules 2026; 354 doi: 10.1016/j.ijbiomac.2026.151318
|
| 13 |
Linglan Suo, Yangling Xiang, Guiqiu Zhou, Xin Ma, Dayong Ren, Yue Leng. Heat-inactivated Akkermansia muciniphila AKK PROBIO attenuates hyperuricemia via integrated modulation of uric acid metabolism, TLR4/NF-κB/NLRP3 pathway, and gut microbiota. Biochemical and Biophysical Research Communications 2026; 797 doi: 10.1016/j.bbrc.2025.153174
|
| 14 |
Nurshad Ali. Interactions between serum uric acid and gut microbiota: implications for metabolic health. Metabolism Open 2026; 29 doi: 10.1016/j.metop.2025.100438
|
| 15 |
Wenqian Zheng, Zhirong Wang, Yunzhe Jia, Shuyao Sang, Zhenquan Yang, Xiangfeng Zheng. Hypouricemic effect and mechanism of chitooligosaccharide‐ionic water in hyperuricemic mice. Journal of the Science of Food and Agriculture 2026; doi: 10.1002/jsfa.71069
|
| 16 |
Di Wang, Jingyu Sun, Guoxiong Wang, Qiuxiong Huang, Huilin Tu, Lihua Zhu, Yajun Lin. Edible dock protein ameliorates hyperuricemia in mice: A multi-omics analysis implicating the gut–kidney axis. Journal of Functional Foods 2026; 140 doi: 10.1016/j.jff.2026.107288
|
| 17 |
Xuezhi Yu, Yang Zhang, Konchun Sun, Rui Yang, Xingde Li, Xiuzhen Chen, Tiantian Li, Xiaolei Yang, Ming Li, Lu Liu, Fei Li, Baochun Shen. 6'‑O‑Caffeoylarbutin attenuates experimental hyperuricemia by regulating renal and intestinal urate transport, intestinal barrier integrity, and gut microbiota. Molecular Medicine Reports 2026; 34(4) doi: 10.3892/mmr.2026.13992
|
| 18 |
Soledad Bouquez, Paola López Campos, Macarena Ottobre, Maite Duhalde-Vega. Anti-hyperuricemia therapy alleviates diet-induced gut inflammation via AhR-IL-22-signalling. Journal of Molecular Medicine 2026; 104(1) doi: 10.1007/s00109-026-02713-6
|
| 19 |
Hongyu Zhang, Da Wang, Chaoran Li, Fengchen Xu, Xiangheng Cao, Bingkun Bao, Mengge Zhao, Xuebo Liu. Comprehensive Evaluation of the Antihyperuricemic Effect of Red Kidney Bean Anthocyanins and Molecular Screening of the Lead Candidate. Journal of Agricultural and Food Chemistry 2026; 74(1) doi: 10.1021/acs.jafc.5c14579
|
| 20 |
Orsolya I. Gaal, Leo A.B. Joosten, Tania O. Crișan. Targeting innate immune memory: a new paradigm for gout treatment. Exploration of Musculoskeletal Diseases 2025; 3 doi: 10.37349/emd.2025.1007103
|
| 21 |
Wujin Chen, Tingting Tian, Jingru Zhou, Dan Yang, Meiting Liang, Yi He, Shanshan Yang, Dilinuer Aikepa, Yuping Sun. Safety Evaluation of Human-Derived Uric Acid Degrading Lacticaseibacillus paracasei M2a and Its Impact on Gut Microbiota. Probiotics and Antimicrobial Proteins 2026; 18(1) doi: 10.1007/s12602-025-10562-x
|
| 22 |
Supriti Patnaik, Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Senthilkumar Krishnamoorthi, Ashok Iyaswamy, Shiva Prasad Mandavi, Rajesh Jeewon, Leonard L Williams. Role of <i>Candida</i> species in pathogenesis, immune regulation, and prognostic tools for managing ulcerative colitis and Crohn's disease. World Journal of Gastroenterology 2024; 30(48): 5212-5220 doi: 10.3748/wjg.v30.i48.5212
|
| 23 |
Jia-Wei Tang, Alfred Chin Yen Tay, Liang Wang. Interpretive prediction of hyperuricemia and gout patients via machine learning analysis of human gut microbiome. BMC Microbiology 2025; 25(1) doi: 10.1186/s12866-025-04125-x
|
| 24 |
Yuxin Jiang, Xiaoyu Shi, Qian Yang, Jianxin Pang, Peng Zhan, Shujing Xu, Ting Wu. Gut microbiota-mediated uric acid metabolism: Novel insights for developing urate-lowering and anti-gout medications. Pharmaceutical Science Advances 2026; 4 doi: 10.1016/j.pscia.2026.100148
|
| 25 |
Haochen Li, Huijie Zhou, Mingzhen Li, Jinglin Wu, Lei Pan. The roles of gut microbiota and their metabolites in uric acid–related metabolic diseases: mechanisms and therapeutic targets. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1781413
|
| 26 |
Hua-Jun Zhang, Shui-Quan Jin, Ding-Jun Cai, Zhi-Peng He. Herbal medicine beyond probiotics: Yiyi Fuzi Baijiang powder and the holistic regulation of gut microbiota in ulcerative colitis. World Journal of Gastroenterology 2026; 32(1): 115543 doi: 10.3748/wjg.v32.i1.115543
|
| 27 |
Xiaoxue Hou, Mengmeng Wang, Tongyuan Hu, Zhinan Wu, Hewei Liang, Yiyi Zhong, Zhihui Ma, Haifeng Zhang, Liang Xiao, Wenjin Zhang, Yuanqiang Zou. Evaluation of the safety and probiotic properties of Limosilactobacillus fermentum BGI-AF16, a uric acid-lowering probiotic strain. Microbial Pathogenesis 2025; 201 doi: 10.1016/j.micpath.2025.107382
|
| 28 |
Fang Yao, Hongsheng Ding, Bin Du, Jing Ma, Mengzhu Jin. Mechanism of Smilacis Glabrae Rhizoma regulating the ERK/JNK/p38 MAPK pathways in a HaCaT cell model induced by IL-17 under hyperuricemic conditions. Journal of Radiation Research and Applied Sciences 2026; 19(2) doi: 10.1016/j.jrras.2026.102491
|
| 29 |
Guizhen Zhu, Yuan Luo, Xiangyi Zheng, Zhusong Mei, Qiao Ye, Jie Peng, Fengsen Duan, Yueying Cui, Peiyu An, Yangqian Song, Hongxia Li, Haitao Zhang, Guangyun Wang. Multi-Omics Mechanism of Chronic Gout Arthritis and Discovery of the Thyroid Hormone–AMPK–Taurine Metabolic Axis. Cells 2025; 15(1) doi: 10.3390/cells15010041
|
| 30 |
Qisijing Liu, Wentao Gu, Juan Ma, Jin Wang, Miao Yu, Min Xu, Shuo Wang. A Pilot Randomized Controlled Trial and Multi-Omics Analysis of Electrolysed Alkaline Water: Impacts on Gut Microbiota and Metabolic Signatures in Hyperuricemia. Nutrients 2025; 18(1) doi: 10.3390/nu18010107
|
| 31 |
Yan Xiao, Ting Zhang, Qianglong Chen, Yiqian Zhang, Bingyan Chen, Meiling Wang, Yingjie Zhang, Mingqing Huang, Youxin Su, Jiemei Guo. Multi-omics analysis reveals the mechanism of verbenalin in treating gout via modulating purine metabolism, gut microbiota, and inflammatory pathways. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1761558
|
| 32 |
学志 余. Research Progress on the Role of Natural Active Ingredients and Traditional Chinese Medicine Compound in Improving Hyperuricemia through Gut-Mediated Pathways. Advances in Clinical Medicine 2026; 16(01) doi: 10.12677/acm.2026.161310
|
| 33 |
Yujiang Cui, Wei Sun, Lijuan Wei, Shuang Fan, Qian Li, Liwei Duan. Complex interactions of gut-derived short-chain fatty acids in hyperuricemia and gout pathophysiology. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1772631
|
| 34 |
Junyu Yang, Jiali Chen, Zhenmin Liu, Yezhi Qu, Xiqing Yue, Bo Yuan, Mohan Li. The Role of the Intestinal Microbiome in the Pathogenesis and Treatment of Hyperuricemia: A Review. Food Science & Nutrition 2025; 13(10) doi: 10.1002/fsn3.70982
|
| 35 |
Francesca K. Martino, Marco Bogo, Ludovica Brunetta, Francesca Fioretti, Leda Cattarin, Lucia F Stefanelli, Federico Nalesso. Calcineurin Inhibitors and Uric Acid Control in Solid Organ Transplantation: A Systematic Review. Medical Sciences 2026; 14(2) doi: 10.3390/medsci14020191
|
| 36 |
Yi-Feng Zou, Tian-Yi Wu, Zi-Qi Liu, Chang-Le Dong, Cheng-Ming Hu, Yin-Sheng Qiu, Zhi-Nan Mei, Ling-Yun Xu.
Poria cocos
and
Poria cocos
polysaccharide chewable tablets: formulation development, quality evaluation and
in vivo
effects on hyperuricemic nephropathy
. Journal of Asian Natural Products Research 2026; doi: 10.1080/10286020.2026.2661278
|
| 37 |
Aamir Saleem, Bushra Walayat, Qidi Xue, Immad Ansari, Xiaoqing Wei, Ming Li. Phragmites Communis (Lu Gen) Alleviates Hyperuricemia via Xanthine Oxidase Inhibition and Gut-Microbiota-Mediated Metabolite Urate Transporter Regulation. Pharmaceuticals 2026; 19(9) doi: 10.3390/ph19091474
|
| 38 |
Qiaoyi Wang, Li Yan, Yufeng Mo, Yuzhu Dai, Jun Cheng, Minli Qiu. Research progress on the correlation between gut microbiota and the occurrence of hyperuricemia. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1763753
|
| 39 |
Rong Qin, Peng Yu, Hui Wang, Jing Zhou, Rui Gong, Yiyao Duan, Hongping Jia, Mingzhu Xie, Yucheng Zhou, Jun Hu. Gut-bone axis crosstalk: Microbiota-driven immune-metabolic-neural networks in bone disorders and precision interventions. Journal of Orthopaedic Translation 2026; 58 doi: 10.1016/j.jot.2026.101126
|
| 40 |
Danping Zhao, Yuannan Wang, Tingting He, Yingna Chen, Yu Bai, Yuchun Huang, Kaiyue Ding, Junnan Ma, Lin Zhang. Puerariae lobatae Radix aqueous extract ameliorates asymptomatic hyperuricemia in a potassium oxonate-induced rat model by dual modulation of uric acid production and excretion. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1685674
|
| 41 |
Xinru Huang, Hao Wu, Xiao Wu, Weiwei Su, Peibo Li. Naringenin/naringin therapeutic effects and the role of intestinal microflora in them. Pharmacological Research 2025; 219 doi: 10.1016/j.phrs.2025.107871
|
| 42 |
Yujing Cui, Haoyue Guan, Samuel Kumi Okyere, Zixuan Hua, Youtian Deng, Huidan Deng, Zhihua Ren, Junliang Deng. Microbial Guardians or Foes? Metagenomics Reveal Association of Gut Microbiota in Intestinal Toxicity Caused by DON in Mice. International Journal of Molecular Sciences 2025; 26(4) doi: 10.3390/ijms26041712
|
| 43 |
Yueying Cui, Peiyu An, Feng Li, Fengsen Duan, Zusong Mei, Qiao Ye, Guangyun Wang, Haitao Zhang, Yuan Luo. Strategies to reduce uric acid through gut microbiota intervention. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1654152
|
| 44 |
Xin Sun, Le Yang, Ye Sun, Hui Sun, Xueping Zhao, Hui Sun, Guangli Yan, Xijun Wang. Natural products (NPs) for gout treatment in multiple targets and pathways. British Journal of Pharmacology 2026; doi: 10.1111/bph.70342
|
| 45 |
Wenrui Shi, Hongzhu Qu, Xiangdong Fang. The Progress of Gout Prediction Models Based on Multi-source Data. Current Rheumatology Reviews 2026; 22(3) doi: 10.2174/0115733971444947260203111252
|
| 46 |
Yang Zhang, Fanyi He, Xuezhi Yu, Tiantian Li, Li Zhou, Baochun Shen. Hyperuricemia-induced kidney injury: a narrative review of mechanisms and therapeutic advances. BMC Nephrology 2025; 26(1) doi: 10.1186/s12882-025-04414-7
|